SCHEMBL20725153

SCHEMBL20725153

COCCOc1ccc(Cn2c(=O)oc3ccc(C)cc32)cc1

nearest known ligand 0.81

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.67
▸ SMN1; SMN2 Q16637 4/20 0.65
▸ TP53 P04637 1/20 0.65
▸ MAPT P10636 1/20 0.65
▸ KMT2A Q03164 3/20 0.65
▸ MIF P14174 2/20 0.64
▸ CD74 P04233 1/20 0.64
▸ THRB P10828 1/20 0.64
▸ TDP1 Q9NUW8 1/20 0.64
▸ TSHR P16473 4/20 0.63
▸ HTT P42858 3/20 0.63
▸ LMNA P02545 2/20 0.63
▸ RAB9A P51151 3/20 0.61
▸ KDM4E B2RXH2 1/20 0.60
▸ MEN1 O00255 2/20 0.60
▸ NPC1 O15118 1/20 0.60
▸ POLB P06746 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20725151 0.87 MIF (0.76) ALDH1A1SMN1; SMN2TP53MAPTKMT2A
SCHEMBL20725152 0.81 TP53 (0.55) ALDH1A1TP53MAPTKMT2AMIF
SCHEMBL18805691 0.79 MIF (0.80) ALDH1A1SMN1; SMN2TP53MAPTKMT2A
SCHEMBL18805676 0.79 KMT2A (0.76) ALDH1A1SMN1; SMN2KMT2AMIFCD74
SCHEMBL16948357 0.79 ALDH1A1 (0.73) ALDH1A1SMN1; SMN2TP53MAPTKMT2A
SCHEMBL10874258 0.79 MIF (1.00) ALDH1A1SMN1; SMN2TP53KMT2AMIF
SCHEMBL14822539 0.78 MAPT (0.70) ALDH1A1SMN1; SMN2TP53MAPTKMT2A
SCHEMBL31667438 0.77 MIF (0.71) ALDH1A1SMN1; SMN2TP53MAPTKMT2A
SCHEMBL10181870 0.76 MAPT (0.75) ALDH1A1SMN1; SMN2TP53MAPTKMT2A
SCHEMBL2757851 0.76 MIF (1.00) ALDH1A1SMN1; SMN2KMT2AMIFCD74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10202343-B2 MIF modulators YALE UNIVERSITY (US) 2019-02-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10202343-B2 MIF modulators MIF, HMGB2, HMGB3 ALDH1A1 584/4885SMN1; SMN2 3531/4885TP53 1948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback